NASDAQ:CVRX

Cvrx Stock Insider Trading

Healthcare > Medical - Devices

Buy CVRX

*Your capital is at risk

$5.15

+0.290 (+5.97%)

At Close: Jun 23, 2026

CVRx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 70.69. In total, the insiders bought 3.49M and sold 100.92K CVRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	70.69
● Buy	3.49M shares
● Sell	100.92K shares
87% Buy Activity Weak Positive Correlation
Buy Signal High Confidence Feb 27, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 70.69. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (87% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 12, 2025 Buy	Common Stock P-Purchase	Hykes Kevin Pres & CEO	CEO / President	5 000 Value: $24.2K
May 12, 2025 Buy	Common Stock P-Purchase	Hykes Kevin Pres & CEO	CEO / President	5 000 Value: $24.2K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Hykes Kevin Pres & CEO	CEO / President	148 000 Value: $1.92M
Feb 28, 2025 Buy	Common Stock A-Award	Hykes Kevin Pres & CEO	CEO / President	98 000 Value: $1.27M
Feb 28, 2025 Buy	Common Stock A-Award	John Robert Allen Chief Revenue Officer	Officer	55 000 Value: $712.8K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	John Robert Allen Chief Revenue Officer	Officer	38 000 Value: $492.5K
Feb 28, 2025 Buy	Common Stock A-Award	Oasheim Jared Chief Financial Officer	C-Suite Officer	22 000 Value: $285.1K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Oasheim Jared Chief Financial Officer	C-Suite Officer	33 000 Value: $427.7K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Adamson Philip B. Chief Medical Officer	Officer	30 000 Value: $388.8K
Feb 28, 2025 Buy	Common Stock A-Award	Adamson Philip B. Chief Medical Officer	Officer	20 000 Value: $259.2K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Verrastro Paul Chief Mktg & Strat Officer	Officer	24 000 Value: $311.0K
Feb 28, 2025 Buy	Common Stock A-Award	Verrastro Paul Chief Mktg & Strat Officer	Officer	16 000 Value: $207.4K
Feb 28, 2025 Buy	Common Stock A-Award	Verrastro Paul Chief Mktg & Strat Officer	Officer	16 000 Value: $207.4K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Verrastro Paul Chief Mktg & Strat Officer	Officer	24 000 Value: $311.0K
Feb 28, 2025 Buy	Common Stock A-Award	Adamson Philip B. Chief Medical Officer	Officer	20 000 Value: $259.2K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Adamson Philip B. Chief Medical Officer	Officer	30 000 Value: $388.8K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Oasheim Jared Chief Financial Officer	C-Suite Officer	33 000 Value: $427.7K
Feb 28, 2025 Buy	Common Stock A-Award	Oasheim Jared Chief Financial Officer	C-Suite Officer	22 000 Value: $285.1K
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	John Robert Allen Chief Revenue Officer	Officer	38 000 Value: $492.5K
Feb 28, 2025 Buy	Common Stock A-Award	John Robert Allen Chief Revenue Officer	Officer	55 000 Value: $712.8K
Feb 28, 2025 Buy	Common Stock A-Award	Hykes Kevin Pres & CEO	CEO / President	98 000 Value: $1.27M
Feb 28, 2025 Buy	Stock Option (right to buy) A-Award	Hykes Kevin Pres & CEO	CEO / President	148 000 Value: $1.92M
Feb 04, 2025 Buy	Stock Option (right to buy)	Adamson Philip B. Chief Medical Officer	Officer	190 208 Value: $1.49M
Feb 04, 2025 Buy	Stock Option (right to buy)	Adamson Philip B. Chief Medical Officer	Officer	190 208 Value: $1.49M
Nov 19, 2024 Buy	Stock Option (right to buy) M-Exempt	Verrastro Paul Chief Mktg & Strat Officer	Officer	2 500 Value: $12.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CVRX, INC.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributo...

Read Full Profile Here